| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |